II
Inmedix, Inc.
SEC filingBiotechnology · Normandy Park, WA
Amount raised$160Ksold at filing
Total offering$5M$4.8M still open
Investors in the raise4count reported to the SEC
FiledOct 6, 2025first sale Sep 24, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Bernie TobinDirector
Andrew Holman, M.D.Executive Officer, Director
Steven Daly, M.S., M.B.A.Director
Leroy Hood, M.D., Ph.D.Director
Kevin Tracey, M.D.Director
Ryan Sullivan, Ph.D.Director
Executive officers, directors and promoters as listed on the Form D.